author-photo

Markus Merilainen

BioMarin Pharmaceutical

3

Papers

68

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria.

2021 Clinical and Translational Science
Show All
- Source
- Cite
- Save
Citations (1)
Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria.

2021 American Journal of Medical Genetics Part A
Show All
- Source
- Cite
- Save
Citations (0)
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)

2018 Molecular Genetics and Metabolism
Show All
- Source
- Cite
- Save
Citations (67)